Mangalam Drugs & Organics is currently trading at Rs. 80.25, up by 7.05 points or 9.63% from its previous closing of Rs. 73.20 on the BSE.
The scrip opened at Rs. 77.50 and has touched a high and low of Rs. 85.00 and Rs. 75.90 respectively. So far 31063 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 225.90 on 29-Dec-2017 and a 52 week low of Rs. 64.20 on 10-Oct-2018.
Last one week high and low of the scrip stood at Rs. 85.00 and Rs. 69.65 respectively. The current market cap of the company is Rs. 124.01 crore.
The promoters holding in the company stood at 50.60%, while Institutions and Non-Institutions held 0.19% and 49.20% respectively.
Mangalam Drugs and Organics has received the WHO Pre-qualification approval for Unit-1. Earlier, this facility was recently inspected by WHO pre-qualification team.
Mangalam Drugs and Organics is an India-based company engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The Company’s segments include bulk drugs, and chemicals and others.
